Skip to main content
. 2015 Aug 25;10(2):336–342. doi: 10.1177/1932296815602099

Table 2.

Median Glucose Concentration, Glycemic Variability, and Time in Target Glucose Range for Patients With Glucose Monitoring and Insulin Dosing by GM1 (Period 1) and GM2 (Period 2).

Period 1 (June-November 2012) Period 2 (August 2013-February 2014) P value
Glucose concentration (mg/dL), median (IQR) 141 (126, 156) 136 (125, 148) .005
Glucose SD (mg/dL), median (IQR) 21.6 (16.9, 26.3) 13.7 (12.4, 19.1) <.0001
Glucose CONGA (mg/dL), median (IQR) 19.4 (16.0, 24.2) 13.5 (10.9, 17.3) <.0001
Percentage glucose values in target range, median (IQR) 66.7 (50.0, 74.2) 74.5 (58.5, 86.7) .002

CONGA, continuous overall net glycemic action; IQR, interquartile range; SD, standard deviation. To convert mg/dL to mmol/L, multiply by 0.0555.